Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 51-61
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.51
Figure 1
Figure 1 Overall survival in patients with hepatocellular carcinoma. A: Overall median survival in the whole cohort; B: Survival curves was stratified by primary treatment modality.
Figure 2
Figure 2 Overall survival according to oncological stage and pre-diagnostic screening characteristics. Patients within Milan (A) or expanded criteria (B), patients who were diagnosed at earlier BCLC stages (C) and patients who had regular follow-up screening for HCC (D) had a significantly better survival (log-rank, P < 0.001). HCC: Hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer.